» Articles » PMID: 37034951

Barriers and Facilitators for Smoking Cessation in Chronic Smokers with Atherosclerotic Cardiovascular Disease Enrolled in a Randomized Intervention Trial: A Qualitative Study

Overview
Journal Front Psychol
Date 2023 Apr 10
PMID 37034951
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Smoking is common in patients with cardiovascular disease. Despite strong recommendations for cessation and the existence of efficacious pharmacological and behavioral interventions, cessation rates remain low. Therefore, in this study, we explore perceived facilitators and barriers to smoking cessation in patients with atherosclerotic cardiovascular disease who have participated in a cessation intervention study.

Methods: Participants ( = 10) from the intervention arm of a randomized controlled study with access to free cessation support and pharmacological aids completed a semi-structured, in-depth telephone interview after a 6-monthfollow-up between October 2021 and July 2022. The interviews were audio recorded, transcribed, and analyzed according to principles of thematic analysis.

Results: The mean age was 65.7 (range: 55-79) years, and three of the 10 participants were women. Among the participants, five had quit smoking, three had relapsed, and two were persistent smokers. The themes identified encompassed barriers and facilitators to cessation, both including individual and contextual factors. Barriers included the upsides of smoking, difficult life situations, addiction to smoking, smoking in social circles, perceived lack of support and understanding from health professionals. Facilitators included intrinsic motivation, concerns about the health condition, financial implications, specific behavioral strategies, positive influence from the social environment, and helpful components of the cessation intervention.

Conclusion: Smokers with cardiovascular disease who have attended a cessation intervention study report several facilitators weighted against barriers, interacting with the intention to cease smoking. The most important potentially modifiable factors of significance for cessation identified may be addressed through motivational interviews and focus groups with other smokers.

Citing Articles

Exploring the Role of Self-Efficacy in Maintaining Healthy Lifestyle Habits among Patients with Cardiometabolic Diseases; Findings from the Multi-Center IACT Cross-Sectional Study.

Kalantzi V, Tsiampalis T, Kouvari M, Belitsi V, Zairis A, Migdanis A Life (Basel). 2024; 14(6).

PMID: 38929719 PMC: 11204498. DOI: 10.3390/life14060736.


A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease: a randomized trial.

Pleym K, Dammen T, Wedon-Fekjaer H, Husebye E, Sverre E, Tonstad S Eur Heart J Open. 2024; 4(2):oeae028.

PMID: 38666249 PMC: 11044967. DOI: 10.1093/ehjopen/oeae028.


Impact of brief smoking cessation intervention on quitting rate and glycemic control in patients with diabetes: a randomized controlled trial.

Ibrahim A, Syed Sulaiman S, Awaisu A, Shafie A J Int Med Res. 2023; 51(10):3000605231208598.

PMID: 37890143 PMC: 10612461. DOI: 10.1177/03000605231208598.

References
1.
Sverre E, Otterstad J, Gjertsen E, Gullestad L, Husebye E, Dammen T . Medical and sociodemographic factors predict persistent smoking after coronary events. BMC Cardiovasc Disord. 2017; 17(1):241. PMC: 5588720. DOI: 10.1186/s12872-017-0676-1. View

2.
Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

3.
Hartmann-Boyce J, Stead L, Cahill K, Lancaster T . Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Addiction. 2014; 109(9):1414-25. DOI: 10.1111/add.12633. View

4.
Dieleman L, van Peet P, Vos H . Gender differences within the barriers to smoking cessation and the preferences for interventions in primary care a qualitative study using focus groups in The Hague, The Netherlands. BMJ Open. 2021; 11(1):e042623. PMC: 7849885. DOI: 10.1136/bmjopen-2020-042623. View

5.
Shiffman S, Paty J, Gnys M, Kassel J, Hickcox M . First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psychol. 1996; 64(2):366-79. DOI: 10.1037//0022-006x.64.2.366. View